Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging
The development of reversibly binding radioligands for imaging brain proteins in vivo, such as enzymes, neurotransmitter transporters, receptors and ion channels, with positron emission tomography (PET) is keenly sought for biomedical studies of neuropsychiatric disorders and for drug discovery and...
Saved in:
Published in | Current medicinal chemistry Vol. 23; no. 18; p. 1818 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United Arab Emirates
01.01.2016
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!